| Financial Year |
March 31 2023 |
| Monetary Funds |
245,964,858.83 |
| Held-for-trading Financial Assets |
25,568,552.21 |
| Notes Receivable |
10,226,223.98 |
| Accounts Receivable |
690,232,549.60 |
| Advances to Suppliers |
99,521,648.76 |
| Other Receivables |
31,310,625.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
446,998,936.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,313,970.04 |
| Total Current Assets |
1,670,797,311.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
41,873,556.73 |
| Investment Properties |
20,120,268.19 |
| Fixed Assetes |
365,425,177.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
208,253,024.55 |
| R&D expenses |
115,515,634.01 |
| Goodwill |
109,253,816.65 |
| Long-Term Deferred and Prepaid Expenses |
9,059,403.93 |
| Deferred Income Tax Assets |
52,510,697.24 |
| Other Non-Current Assets |
15,029,138.98 |
| Sub-Total of Non-Current Assets |
1,114,695,153.25 |
| Total Assets |
2,785,492,464.83 |
| Short-Term Loans |
415,917,850.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
134,964,207.94 |
| Accounts Payable |
329,516,761.45 |
| Accounts Received In Advance |
83,437.68 |
| Employee Compensation Payable |
50,942,130.16 |
| Taxes Payable |
17,187,997.53 |
| Interest Payable |
-269,629.64 |
| Dividend Payable |
-- |
| Other payables |
53,160,120.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
107,871,958.40 |
| Other Current Liabilities |
64,504,198.56 |
| Sub-Total of Current Liabilities |
1,283,779,929.70 |
| Long-term Loans |
42,051,458.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
233,215,066.26 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,506,723.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
459,559,571.25 |
| Total Liabilities |
1,743,339,500.95 |
| Paid-In Capital(Or Share Stock) |
533,117,181.00 |
| Capital Surplus |
1,393,470,162.97 |
| Surplus Reserve |
51,594,085.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,026,366,121.13 |
| Minority Stockholder's Interest |
90,677,384.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
951,475,579.86 |
| Owner's Equity（Stockholder's Equity） |
1,042,152,963.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,785,492,464.83 |
